Sunshine Biopharma (SBFM) Income from Discontinued Operations (2018 - 2019)
Sunshine Biopharma's (SBFM) quarterly Income from Discontinued Operations came in at -$2112.0 in Q3 2019, down 123.28% on a YoY basis from $9071.0 in Q3 2018, and up 99.64% quarter-over-quarter from -$580125.0 in Q2 2019.
Powered by 
Analysis
Sunshine Biopharma (SBFM) Income from Discontinued Operations (2018 - 2019) Analysis & Trends
Sunshine Biopharma (SBFM) has reported Income from Discontinued Operations for 2 consecutive years, with -$2112.0 the latest figure, recorded in Q3 2019.
- For the quarter ending Q3 2019, Income from Discontinued Operations fell 123.28% year-over-year to -$2112.0; the trailing twelve-month figure through Jun 2020 stood at -$2112.0 (up 99.64% YoY), and the FY2019 full-year result was -$582237.0, down 3098.4% from the prior year.
- Income from Discontinued Operations grew to -$2112.0 in Q3 2019 per SBFM's latest filing, from -$580125.0 in the prior quarter.
- Across five years, Income from Discontinued Operations topped out at $9560.0 in Q2 2018 and bottomed at -$580125.0 in Q2 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Discontinued) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.63 Bn | 38.98 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.18 Bn | 18.30 Bn | 1.46 Bn | - |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.68 Bn | 396.53 Mn | - |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.36 Bn | 522.63 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | - |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | - |
| 8 | Amphastar Pharmaceuticals | 995.08 Mn | 704.96 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 406.65 Mn | 365.40 Mn | 17.15 Mn | - |
| 10 | Sunshine Biopharma | 1.56 Mn | -12.19 Mn | 2.43 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2019 | -2,112.00 |
| Jun 30, 2019 | -580,125.00 |
| Mar 31, 2019 | -2,112.00 |
| Dec 31, 2018 | -9,357.00 |
| Sep 30, 2018 | 9,071.00 |
| Jun 30, 2018 | 9,560.00 |